DMRA Q3'26 Earnings Preview: EPS Estimated at (0.48) USD
Damora Therapeutics is scheduled to report Q3'26 results on October 30; the report time is not specified. Revenue is estimated at 0 USD and EPS at (0.48) USD.
DMRA (Damora Therapeutics, Inc.) is set to announce its Q3'26 results on October 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.48) USD. Learn more details at DMRA Fi…